Publications by authors named "A M Lansky"
We assessed mpox vaccine communication and sexual behavior among U.S. MSM during the 2022 mpox outbreak.
View Article and Find Full Text PDFBackground: Coronary artery disease (CAD) is the leading cause of death for women, yet they remain underrepresented in interventional CAD studies. Women have been shown to be at increased risk of mortality and major adverse events after percutaneous coronary intervention (PCI). The poorer outcomes are likely because women are typically diagnosed with CAD late, at an older age, with more comorbidities, and with more challenging anatomy including smaller vessels and higher prevalence of coronary artery calcification.
View Article and Find Full Text PDFResults of SurVeil Versus IN.PACT Admiral Paclitaxel Coated Balloons in Femoropopliteal Arteries: Outcomes of the Randomised TRANSCEND Study Through 24 Months.
Eur J Vasc Endovasc Surg
November 2024
Article Synopsis
- * In this randomized controlled trial involving 446 patients, the SurVeil PCB showed a primary safety rate of 91.8% and a primary efficacy rate of 82.2%, while the IN.PACT Admiral had rates of 89.8% and 85.9%, respectively.
- * The results indicate that the SurVeil PCB is a safe and effective treatment option, demonstrating non-inferiority to the IN.PACT Admiral PCB over a 24-month period.
Revascularization Strategies in Women: Do Women Benefit as Much as Men?
Interv Cardiol Clin
January 2025
Ischemic heart disease is a leading cause of mortality worldwide. Substantial gaps in knowledge exist in our understanding of gender-related differences in revascularization outcomes. This review aims to highlight the existing evidence of sex-based outcomes in the management of coronary artery disease and cardiogenic shock.
View Article and Find Full Text PDFArticle Synopsis
- The text discusses the challenges in treating below-the-knee (BTK) lesions, particularly due to their complexity and calcification, with existing studies showing varied outcomes and often excluding severely calcified cases.
- The Disrupt BTK II study aimed to assess the efficacy of intravascular lithotripsy (IVL) on patients with moderate to severe calcification in BTK lesions, enrolling 250 subjects across various sites in the U.S. and Europe, focusing on safety and procedural success.
- The results showed a high procedural success rate of 97.9%, with significant reductions in stenosis after treatment, and no major adverse limb events reported at the 30-day mark, indicating IVL may be an effective option